Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Garofalo Health Care SpAMIL:GHC +0.38%85 Days Sales Outstanding is 89.47 as of Jun. 2026, which is 2% above its 10-year median of 87.43. GuruFocus rates MIL:GHC with a GF Score™ of 85/100 and a GF Value™ of €5.75 (Fairly Valued). The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Garofalo Health Care SpA ranks worse than 81.02% on this metric.
The historical rank and industry rank for Garofalo Health Care SpA's Days Sales Outstanding or its related term are showing as below:
MIL:GHC'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 83.43 Med: 87.43 Max: 108.41
Current: 93.71
During the past 11 years, Garofalo Health Care SpA's highest Days Sales Outstanding was 108.41. The lowest was 83.43. And the median was 87.43.
MIL:GHC's Days Sales Outstanding is ranked worse than 81.02% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 45.78
vs MIL:GHC: 93.71
Garofalo Health Care SpA's Days Sales Outstanding
declined
from Jun. 2025 (102.82) to Jun. 2026 (89.47).
Garofalo Health Care SpA (MIL:GHC) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Garofalo Health Care SpA Days Sales Outstanding Related Terms
Garofalo Health Care SpA Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Garofalo Health Care SpA's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Garofalo Health Care SpA Days Sales Outstanding Chart
MIL:GHC vs HCA, THC, EHC: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Garofalo Health Care SpA's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Garofalo Health Care SpA Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Garofalo Health Care SpA's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Garofalo Health Care SpA's Days Sales Outstanding falls into.
Garofalo Health Care SpA Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Garofalo Health Care SpA (MIL:GHC) has a Days Sales Outstanding of 89.47 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Garofalo Health Care SpA and its competitors. This is near median its historical median of 87.43. Over the past decade, Garofalo Health Care SpA's Days Sales Outstanding has ranged from 83.43 to 108.41. According to the industry distribution chart, Garofalo Health Care SpA ranks #538 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 81%.
Is Garofalo Health Care SpA's Days Sales Outstanding too high?
Garofalo Health Care SpA's current Days Sales Outstanding of 89.47 is near median its 10-year median of 87.43. Over the past 10 years, this metric has ranged from a low of 83.43 to a high of 108.41. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.78. Garofalo Health Care SpA's value of 89.47 is 95.4% above this industry median. Based on the distribution chart, Garofalo Health Care SpA ranks #538 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Garofalo Health Care SpA has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Garofalo Health Care SpA's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Garofalo Health Care SpA ranks #538 out of 664 companies for Days Sales Outstanding. This places Garofalo Health Care SpA in the lower half of its industry. The industry median Days Sales Outstanding is 45.78. Garofalo Health Care SpA's value of 89.47 is 95.4% above this benchmark. Historically, Garofalo Health Care SpA's own Days Sales Outstanding has ranged from 83.43 to 108.41 over the past decade. While the company's 10-year median is 87.43 vs. the industry median of 45.78, Garofalo Health Care SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.78, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Garofalo Health Care SpA's current Days Sales Outstanding of 89.47 is 95.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Garofalo Health Care SpA and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Garofalo Health Care SpA's current Days Sales Outstanding is 89.47, which is near median its own 10-year median of 87.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Garofalo Health Care SpA stock overvalued right now?
Based on GuruFocus' analysis, Garofalo Health Care SpA (MIL:GHC) is currently considered Fairly Valued. The stock's GF Value™ is €5.75, compared to a current price of €5.32 — trading 7.5% below its estimated fair value. The current Days Sales Outstanding is 89.47, which is near median its 10-year median of 87.43 and 95.4% above the Healthcare Providers & Services industry median of 45.78. Garofalo Health Care SpA's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Garofalo Health Care SpA (MIL:GHC), the current Days Sales Outstanding is 89.47 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Garofalo Health Care SpA (MIL:GHC) Overvalued in 2026?
Based on GuruFocus' analysis, Garofalo Health Care SpA stock appears to be undervalued.
The current stock price of €5.32 is trading 7.5% below its estimated GF Value™ of €5.75.
GuruFocus considers Garofalo Health Care SpA to be Fairly Valued.
Key valuation signals for MIL:GHC:
Days Sales Outstanding: 89.47 (near median its 10-year median of 87.43)
GF Value™: €5.75 vs. price of €5.32 (7.5% below fair value)
Industry Position: 95.4% above the Healthcare Providers & Services median (#538 of 664)
No single metric tells the full story. See the MIL:GHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Garofalo Health Care SpA is an Italian accredited private healthcare provider offering a comprehensive range of services across various areas of healthcare through diversified specialties, supported by the use of technologies and qualified personnel. The Group mainly operates in regions of northern and central Italy, which have been selected based on their attractiveness in terms of per capita healthcare spending, above-average per capita income, and well-developed internal transport infrastructure.
85GF Score
Get the complete analysis for MIL:GHC
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:GHC has been successfully added to your 
